DAVID M MOTT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DAVID M MOTT.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is a Vice Chairman and CEO in MEDIMMUNE INC /DE ($MEDI) and a 10% Owner in ARCA biopharma, Inc. ($ABIO) and a 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and a 10% Owner in Achaogen Inc ($AKAO) and a 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and a 10% Owner in MULESOFT, INC ($MULE) and a 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and a 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and a 10% Owner in Care.com Inc ($CRCM) and a Director in ARDELYX, INC. ($ARDX) and a 10% Owner in APPIAN CORP ($APPN) and a Director in Mersana Therapeutics, Inc. ($MRSN) and a 10% Owner in Roka BioScience, Inc. ($ROKA) and a 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and a Director in TESARO, Inc. ($TSRO) and a 10% Owner in Regulus Therapeutics Inc. ($RGLS) and a 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and a 10% Owner in Cerecor Inc. ($CERC) and a 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and a Director in Epizyme, Inc. ($EPZM) and a Director in Adaptimmune Therapeutics PLC ($ADAP) and a 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a 10% Owner in Elastic N.V. ($ESTC) and a Director in Nightstar Therapeutics plc ($NITE) and a 10% Owner in Surface Oncology, Inc. ($SURF).

Over the past year DAVID M MOTT has been an insider in 10 companies. The total value of shares held by DAVID M MOTT in these companies amounts to $394,938,662.

DAVID M MOTT 10% Owner
Achaogen, Inc.
Director
Adaptimmune Therapeutics PLC
10% Owner
APPIAN CORP
10% Owner
ARCA biopharma, Inc.
Director
ARDELYX, INC.
10% Owner
AVEO PHARMACEUTICALS INC
10% Owner
Care.com Inc
10% Owner
Cascadian Therapeutics, Inc.
10% Owner
Cerecor Inc.
10% Owner
Elastic N.V.
Director
Epizyme, Inc.
10% Owner
INTERLEUKIN GENETICS INC
Vice Chairman and CEO
MEDIMMUNE INC /DE
Director
Mersana Therapeutics, Inc.
10% Owner
MULESOFT, INC
Director
Nightstar Therapeutics plc
10% Owner
Ra Pharmaceuticals, Inc.
10% Owner
Regulus Therapeutics Inc.
10% Owner
RHYTHM PHARMACEUTICALS, INC.
10% Owner
Sorrento Tech, Inc.
10% Owner
Surface Oncology, Inc.
10% Owner
SYNLOGIC, INC.
Director
TESARO, Inc.
10% Owner
Tracon Pharmaceuticals, Inc.
10% Owner
Trevi Therapeutics, Inc.
$ 394938662 The total value of shares held by DAVID M MOTT
Insider Rank

DAVID M MOTT ranks 198 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: 35 WEST WATKINS MILL ROAD GAITHERSBURG 20878 MD

Companies in which DAVID M MOTT is an Insider

Achaogen, Inc.

Trading Symbol: AKAO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 5,215,128 shares
Current Value: $98,305,163
Latest Transaction: Dec 19 2016
$AKAO Market Capitalization: $541.33M
$AKAO Previous Close: $18.85

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 500,000
Shares Sold: 0
Share Difference: +500,000
Value Difference: -$6,750,000

Adaptimmune Therapeutics PLC

Trading Symbol: ADAP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: Director
Holdings: 82,978,668 shares
Current Value: $375,893,366
Latest Transaction: Sep 10 2018
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 8x
Sell: 0x
Shares Bought: 35,709,672
Shares Sold: 0
Share Difference: +35,709,672
Value Difference: -$49,015,100

APPIAN CORP

Trading Symbol: APPN
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of DAVID M MOTT: 10% Owner
Holdings: 2,724,202 shares
Latest Transaction: Feb 15 2018

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 9x
Sell: 5x
Shares Bought: 6,171,127
Shares Sold: 6,155,201
Share Difference: +15,926
Value Difference: +$66,073,750

ARCA biopharma, Inc.

Trading Symbol: ABIO
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DAVID M MOTT: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 27 2018
$ABIO Market Capitalization: $23.40M
$ABIO Previous Close: $2.60

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 1x
Shares Bought: 0
Shares Sold: 1,460,209
Share Difference: -1,460,209
Value Difference: +$731,273

ARDELYX, INC.

Trading Symbol: ARDX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 54,720 shares
Current Value: $604,656
Latest Transaction: Jun 15 2018
$ARDX Market Capitalization: $529.77M
$ARDX Previous Close: $11.05

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 13x
Sell: 0x
Shares Bought: 6,991,436
Shares Sold: 0
Share Difference: +6,991,436
Value Difference: -$56,666,684

AVEO PHARMACEUTICALS INC

Trading Symbol: AVEO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 25,243,865 shares
Current Value: $15,398,758
Latest Transaction: Apr 08 2019
$AVEO Market Capitalization: $45.51M
$AVEO Previous Close: $0.61

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 28x
Sell: 0x
Shares Bought: 15,051,171
Shares Sold: 0
Share Difference: +15,051,171
Value Difference: -$17,457,594

Care.com Inc

Trading Symbol: CRCM
Industry: SERVICES-PERSONAL SERVICES [7200]
Position of DAVID M MOTT: 10% Owner
Holdings: 2,256,013 shares
Current Value: $21,071,161
Latest Transaction: Nov 08 2017
$CRCM Market Capitalization: $283.29M
$CRCM Previous Close: $9.34

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 2x
Shares Bought: 12,806
Shares Sold: 1,010,000
Share Difference: -997,194
Value Difference: $0

Cascadian Therapeutics, Inc.

Trading Symbol: CASC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of DAVID M MOTT: 10% Owner
Holdings: 0 shares
Latest Transaction: Mar 13 2018

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 1x
Shares Bought: 0
Shares Sold: 10,882,574
Share Difference: -10,882,574
Value Difference: $0

Cerecor Inc.

Trading Symbol: CERC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 594,245 shares
Current Value: $493,223
Latest Transaction: Oct 20 2015
$CERC Market Capitalization: $7.38M
$CERC Previous Close: $0.83

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Elastic N.V.

Trading Symbol: ESTC
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of DAVID M MOTT: 10% Owner
Holdings: 4,155,995 shares
Latest Transaction: Oct 10 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 5,684,112
Shares Sold: 0
Share Difference: +5,684,112
Value Difference: $0

Epizyme, Inc.

Trading Symbol: EPZM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 13,979 shares
Current Value: $168,447
Latest Transaction: Jun 07 2019
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 0x
Shares Bought: 630,646
Shares Sold: 0
Share Difference: +630,646
Value Difference: -$6,967,905

INTERLEUKIN GENETICS INC

Trading Symbol: ILIU
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DAVID M MOTT: 10% Owner
Holdings: 55,418,811 shares
Current Value: $5,541,881
Latest Transaction: Aug 02 2016
$ILIU Market Capitalization: $22.11M
$ILIU Previous Close: $0.10

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 20,120,724
Shares Sold: 0
Share Difference: +20,120,724
Value Difference: -$2,000,000

MEDIMMUNE INC /DE

Trading Symbol: MEDI
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: Vice Chairman and CEO
Holdings: 0 shares
Latest Transaction: Mar 10 2004

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Mersana Therapeutics, Inc.

Trading Symbol: MRSN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 11,890,138 shares
Latest Transaction: Jun 11 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 11,890,138
Shares Sold: 0
Share Difference: +11,890,138
Value Difference: -$30,000,000

MULESOFT, INC

Trading Symbol: MULE
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of DAVID M MOTT: 10% Owner
Holdings: 12,679,970 shares
Latest Transaction: May 09 2018

Last 4 weeks trend: SELL
Last 3 months trend: SELL View transactions

Last 3 Months Overview:
Buy: 6x
Sell: 6x
Shares Bought: 31,910,994
Shares Sold: 32,231,774
Share Difference: -320,780
Value Difference: $0

Nightstar Therapeutics plc

Trading Symbol: NITE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: Director
Holdings: 0 shares
Latest Transaction: Jun 07 2019

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 0x
Sell: 1x
Shares Bought: 0
Shares Sold: 6,662,532
Share Difference: -6,662,532
Value Difference: +$169,894,560

Ra Pharmaceuticals, Inc.

Trading Symbol: RARX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 80,658 shares
Current Value: $1,465,556
Latest Transaction: Oct 31 2016
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 5x
Sell: 1x
Shares Bought: 3,490,508
Shares Sold: 435
Share Difference: +3,490,073
Value Difference: -$4,399,997

Regulus Therapeutics Inc.

Trading Symbol: RGLS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 2,052,454 shares
Current Value: $2,873,436
Latest Transaction: May 09 2019
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 1,136,704
Shares Sold: 0
Share Difference: +1,136,704
Value Difference: -$1,227,640

RHYTHM PHARMACEUTICALS, INC.

Trading Symbol: RYTM
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 1,432,248 shares
Latest Transaction: Oct 10 2017

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 4,880,578
Shares Sold: 0
Share Difference: +4,880,578
Value Difference: -$9,350,000

Sorrento Tech, Inc.

Trading Symbol: ROKA
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of DAVID M MOTT: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 23 2016
$ROKA Market Capitalization: $8.04M
$ROKA Previous Close: $4.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Surface Oncology, Inc.

Trading Symbol: SURF
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: 10% Owner
Holdings: 3,179,544 shares
Latest Transaction: Apr 23 2018

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 4x
Sell: 0x
Shares Bought: 6,625,754
Shares Sold: 0
Share Difference: +6,625,754
Value Difference: -$3,999,990

SYNLOGIC, INC.

Trading Symbol: SYBX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 4,228,940 shares
Current Value: $9,303,668
Latest Transaction: Jan 26 2018
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 3,804,439
Shares Sold: 0
Share Difference: +3,804,439
Value Difference: -$3,997,500

TESARO, Inc.

Trading Symbol: TSRO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 22 2019
$TSRO Market Capitalization: $8.41B
$TSRO Previous Close: $162.95

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 21x
Sell: 4x
Shares Bought: 1,571,718
Shares Sold: 10,437,250
Share Difference: -8,865,532
Value Difference: +$724,439,552

Tracon Pharmaceuticals, Inc.

Trading Symbol: TCON
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: 10% Owner
Holdings: 3,466,003 shares
Current Value: $17,156,715
Latest Transaction: Mar 27 2018
$TCON Market Capitalization: $64.02M
$TCON Previous Close: $4.95

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 1,577,529
Shares Sold: 0
Share Difference: +1,577,529
Value Difference: -$6,911,502

Trevi Therapeutics, Inc.

Trading Symbol: TRVI
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 1,938,562 shares
Latest Transaction: May 13 2019

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 3x
Sell: 0x
Shares Bought: 4,438,562
Shares Sold: 0
Share Difference: +4,438,562
Value Difference: -$25,000,000

Latest Insider Trading Transactions of DAVID M MOTT

Sentiment: All, AKAO, ADAP, APPN, ABIO, ARDX, AVEO, CRCM, CASC, CERC, ESTC, EPZM, ILIU, MEDI, MRSN, MULE, NITE, RARX, RGLS, RYTM, ROKA, SURF, SYBX, TSRO, TCON, TRVI

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 11 2019MRSNMersana Therapeuti ...MOTT DAVID MDirectorOption ExerciseA4.3125,000107,75025,000
Jun 07 2019EPZMEpizyme, Inc.MOTT DAVID MDirectorOption ExerciseA13.7417,633242,27717,633
Jun 07 2019EPZMEpizyme, Inc.MOTT DAVID MDirectorGrantA12.391,89123,42913,97912.1 K to 14 K (+15.64 %)
Jun 07 2019NITENightstar Therapeu ...MOTT DAVID MDirectorOption ExerciseD13.5721,000284,9700
Jun 07 2019NITENightstar Therapeu ...MOTT DAVID MDirectorOption ExerciseD12.2736,400446,6280
Jun 07 2019NITENightstar Therapeu ...MOTT DAVID MDirectorSellD25.506,662,532169,894,56606.7 M to 0 (-100.00 %)
May 13 2019TRVITrevi Therapeutics ...MOTT DAVID M10% OwnerOption ExerciseC0.0017,099,31500

View all DAVID M MOTT insider transactions.